USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY

被引：0
|
作者：
McInnes, I. B. [1 ]
Kavanaugh, A. [2 ]
Gottlieb, A. B. [3 ]
Puig, L. [4 ]
Rahman, P. [5 ]
Ritchlin, C. [6 ]
Li, S. [7 ]
Wang, Y. [7 ]
Mendelsohn, A. M. [7 ]
Doyle, M. K. [7 ,8 ]
机构：
[1] U Glasgow, Glasgow, Lanark, Scotland
[2] U Calif, San Diego, CA USA
[3] Tufts Med Cntr, Boston, MA USA
[4] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[5] Mem U, St John, NF, Canada
[6] U Rochester, Rochester, NY USA
[7] Janssen R&D, Spring House, PA USA
[8] U Penn, Philadelphia, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.1841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [21] Secukinumab improves active psoriatic arthritis and inhibits radiographic progression: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study
    Mease, P.
    McInnes, I. B.
    Kirkham, B.
    Kavanaugh, A.
    Rahman, P.
    Van Der Heijde, D.
    Landewe, R.
    Nash, P.
    Pricop, L.
    Yuan, J.
    Richards, H.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
  • [22] Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.
    Kavanaugh, Arthur
    McInnes, Iain B.
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Doyle, Mittie K.
    Mendelsohn, Alan M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4168 - 4168
  • [23] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [24] Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
    Leng, Xiaomei
    Lin, Wei
    Liu, Shixue
    Kanik, Keith
    Wang, Cunshan
    Wan, Weiguo
    Jiang, Zhenyu
    Liu, Yi
    Liu, Shengyun
    Zhang, Zhuoli
    Zhang, Zhiyi
    Xu, Jian
    Tan, Wenfeng
    Hu, Jiankang
    Li, Jingyang
    Liu, Ju
    Gunay, Levent M.
    Dina, Oluwaseyi
    Kinch, Cassandra
    Zeng, Xiaofeng
    RMD OPEN, 2023, 9 (01):
  • [25] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS
    CARETTE, S
    CALIN, A
    MCCAFFERTY, JP
    WALLIN, BA
    ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 158 - 165
  • [26] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136) : 2213 - 2224
  • [27] SULFASALAZINE IN PSORIATIC-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    FARR, M
    KITAS, GD
    WATERHOUSE, L
    JUBB, R
    FELIXDAVIES, D
    BACON, PA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (01): : 46 - 49
  • [28] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Choy, EHS
    Sharp, JT
    Ory, PA
    Perdok, RJ
    Weinberg, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
  • [29] EFFICACY AND SAFETY OF USTEKINUMAB IN PSA PATIENTS WITH SPONDYLITIS AND PERIPHERAL JOINT INVOLVEMENT: RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    You, Y.
    Wang, Y.
    Mendel-sohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I. B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 825 - 825
  • [30] SECUKINUMAB INHIBITS RADIOGRAPHIC PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS: DATA FROM A PHASE 3 RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (FUTURE 1)
    Van der Heijde, D.
    Landewe, R.
    Mease, P.
    McInnes, I. B.
    Conaghan, P. G.
    Pricop, L.
    Ligozio, G.
    Richards, H.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 347 - 348
12345